Professor of cancer biology
Verified email at
Cited by
Cited by
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy
C Delettre, G Lenaers, JM Griffoin, N Gigarel, C Lorenzo, P Belenguer, ...
Nature genetics 26 (2), 207-210, 2000
CDC25 phosphatases in cancer cells: key players? Good targets?
R Boutros, V Lobjois, B Ducommun
Nature Reviews Cancer 7 (7), 495-507, 2007
The when and wheres of CDC25 phosphatases
R Boutros, C Dozier, B Ducommun
Current opinion in cell biology 18 (2), 185-191, 2006
The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space
A Olichon, LJ Emorine, E Descoins, L Pelloquin, L Brichese, N Gas, ...
FEBS letters 523 (1-3), 171-176, 2002
cdc2 phosphorylation is required for its interaction with cyclin.
B Ducommun, P Brambilla, MA Felix, BR Franza Jr, E Karsenti, G Draetta
The EMBO journal 10 (11), 3311-3319, 1991
p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells
C Cayrol, M Knibiehler, B Ducommun
Oncogene 16 (3), 311-320, 1998
Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
S Ait-Si-Ali, S Ramirez, FX Barre, F Dkhissi, L Magnaghi-Jaulin, JA Girault, ...
Nature 396 (6707), 184-186, 1998
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2–M transition
S Dutertre, M Cazales, M Quaranta, C Froment, V Trabut, C Dozier, ...
Journal of cell science 117 (12), 2523-2531, 2004
Distinct nuclear and spindle pole body populations of cyclin–cdc2 in fission yeast
CE Alfa, B Ducommun, D Beach, JS Hyams
Nature 347 (6294), 680-682, 1990
Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage
T Ando, T Kawabe, H Ohara, B Ducommun, M Itoh, T Okamoto
Journal of Biological Chemistry 276 (46), 42971-42977, 2001
Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation.
C Comayras, C Tasca, SY Pérès, B Ducommun, E Oswald, J De Rycke
Infection and immunity 65 (12), 5088-5095, 1997
Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
F Goubin, B Ducommun
Oncogene 10 (12), 2281-2287, 1995
Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21
C Cayrol, B Ducommun
Oncogene 17 (19), 2437-2444, 1998
CDC25B phosphorylation by Aurora A occurs at the G2/M transition and is inhibited by DNA damage
M Cazales, E Schmitt, E Montembault, C Dozier, C Prigent, B Ducommun
Cell Cycle 4 (9), 1233-1238, 2005
Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21
VN Podust, LM Podust, F Goubin, B Ducommun, U Huebscher
Biochemistry 34 (27), 8869-8875, 1995
Regulation of CDC25B phosphatases subcellular localization
N Davezac, V Baldin, B Gabrielli, A Forrest, N Theis-Febvre, M Yashida, ...
Oncogene 19 (18), 2179-2185, 2000
Cell cycle control by the CDC25 phosphatases
B Aressy, B Ducommun
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2008
Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation
V Baldin, C Cans, M Knibiehler, B Ducommun
Journal of Biological Chemistry 272 (52), 32731-32734, 1997
Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer
I Dufau, C Frongia, F Sicard, L Dedieu, P Cordelier, F Ausseil, ...
BMC cancer 12 (1), 1-11, 2012
Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?
V Baldin, C Cans, G Superti-Furga, B Ducommun
Oncogene 14 (20), 2485-2495, 1997
The system can't perform the operation now. Try again later.
Articles 1–20